Orion published Half-Year Financial Report for January–June 2021 on Monday, 19 July 2021. The report, related presentation material and link to the webcast recording are available here.
The Annual General Meeting of Orion Corporation was held on Thursday 25 March 2021 at Orion's Head Office in Espoo. The decisions and related material are available here.
Orion’s virtual Capital Markets Day 2021 was held on 26 May 2021. Presentations and webcast from the event are available here.
Orion Group's Financial Statement documents for 2020 are available here.
The latest Corporate Governance Statement of Orion Corporation is available at the archive of Corporate Governance Statements.
|7/22/2021||Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)|
|7/21/2021||Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)|
|7/19/2021||Orion Group Half-Year Financial Report 1-6/2021|
|7/19/2021||Orion Corporation's financial reporting and Annual General Meeting in 2022|
|8/3/2021||Orion Corporation signs European wide marketing and distribution agreement with Marinus Pharmaceuticals for ganaxolone|
|7/12/2021||Orion recalls Multivita Forte dietary supplement from consumers|
|7/2/2021||Orion publishes Half-Year Financial Report for January–June 2021 on Monday 19 July 2021|
|6/21/2021||Orion Animal Health’s Tessie® (tasipimidine) receives positive CVMP opinion|
Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.
Research and development are Orion's strengths, and the company will continue to invest in them. The target is to increase net sales 1.5-fold by 2025.